ENOV
ENOV
NYSE · Health Care

Enovis Corp

$21.97
+1.12 (+5.37%)
As of Jun 21, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
2.29B
Net Income
-1,204,010,993
Gross Margin
58.2%
Profit Margin
-52.7%
Rev Growth
+12.9%
D/E Ratio
0.87
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.29B 2.02B 959.49M 1.06B
Gross Profit 1.33B 1.18B 638.34M 705.58M
Operating Income -1,144,650,902 -912,638,033 89.71M 107.61M
Net Income -1,204,010,993 -959,966,241 74.78M 72.61M
Gross Margin 58.2% 58.2% 66.5% 66.5%
Operating Margin -50.1% -45.1% 9.3% 10.1%
Profit Margin -52.7% -50.1% 7.8% 6.9%
Rev Growth +12.9% +12.9% -5.1% -8.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 294.27M 294.27M 570.05M 575.91M
Total Equity 338.05M 338.05M 642.51M 611.09M
D/E Ratio 0.87 0.87 0.89 0.94
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -780,556,149 -656,917,382 123.09M 130.61M
Free Cash Flow 63.08M 92.88M